Cart
sales@molnova.com
1-Adamantylamine
CAS No. 768-94-5
1-Adamantylamine ( Amantadine;1-Adamantanamine;1-Aminoadamantane )
Catalog No. M21211 CAS No. 768-94-5
1-Adamantylamine is an antiviral is a weak antagonist of the NMDA-type glutamate receptor increases dopamine release and blocks dopamine reuptake.?
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 35 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name1-Adamantylamine
-
NoteResearch use only not for human use.
-
Brief Description1-Adamantylamine is an antiviral is a weak antagonist of the NMDA-type glutamate receptor increases dopamine release and blocks dopamine reuptake.?
-
Description1-Adamantylamine is an antiviral is a weak antagonist of the NMDA-type glutamate receptor increases dopamine release and blocks dopamine reuptake.?
-
SynonymsAmantadine;1-Adamantanamine;1-Aminoadamantane
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaCardiovascular Disease
-
IndicationComaHeart ArrestAnoxia
Chemical Information
-
CAS Number768-94-5
-
Formula Weight151.25
-
Molecular FormulaC10H17N
-
Purity>98% (HPLC)
-
SolubilityDMSO:1 mg/mL (6.61 mM)
-
SMILESNC12CC3CC(CC(C3)C1)C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lim J K Wooten D Siegel R et al. Amantadine in treatment of chronic hepatitis C virus infection[J]. Journal of Viral Hepatitis 2005 12(5):445-455.
molnova catalog
related products
-
Obinutuzumab/afutuzu...
Obinutuzumab GA101) a novel glycoengineered Type II CD20 monoclonal antibody in development for non-Hodgkin lymphoma.
-
Isophysalin G
Reference standards. Physalin G analogue.
-
Curculigoside
Curculigoside can prevent bone loss , improve osteogenesis and inhibit osteoclastogenesis of hAFSCs, suggesting its potential use to regulate hAFSC osteogenic differentiation for treating bone disorders.
